Editas Medicine Inc (EDIT) stock news · rev $40.5M
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
This EDIT news page leads with what Editas Medicine Inc filed — not a scraped headline mill.
No cached 8-K sentence for EDIT yet. We will not pad this page with generic market recap.
Latest reported EDIT revenue for 2025-12-31 was $40.5M. Net income was -$160.1M. Revenue was up 25.4% from 2024-12-31 to 2025-12-31. EDIT currently screens at market cap $375.2M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the EDIT stock page; for the tape open the quote page.
EDIT stock news FAQ
What are EDIT's latest revenue and net income?
Latest cached Editas Medicine Inc (EDIT) revenue for Dec 31, 2025 was $40.5M. Net income was -$160.1M. Statements: https://lician.com/financials/edit
How did EDIT revenue change from the prior cached period?
Cached Editas Medicine Inc (EDIT) revenue was up 25.4% from $32.3M (Dec 31, 2024) to $40.5M (Dec 31, 2025). Statements: https://lician.com/financials/edit
What is EDIT's market cap?
Editas Medicine Inc (EDIT) market cap is $375.2M on the latest cached fundamentals snapshot.
What kind of company is EDIT?
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Where is EDIT stock news listed?
Cached stock news for Editas Medicine Inc (EDIT) is listed at https://lician.com/news/edit. Filings: https://lician.com/sec/edit
Not investment advice.